Mission Creek Capital Partners, Inc. Gilead Sciences, Inc. Transaction History

Mission Creek Capital Partners, Inc.

$384 Million
Q1 2024

A detailed history of Mission Creek Capital Partners, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mission Creek Capital Partners, Inc. holds 6,623 shares of GILD stock, worth $454,404. This represents 0.13% of its overall portfolio holdings.

Number of Shares

6,623

Previous 12,282 46.08%

Holding current value

$454,404

Previous $994,000 51.21%

% of portfolio

0.13%

Previous 0.26%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $405,071 - $493,974	-5,659 Reduced 46.08%	6,623 $485,000
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $104,995 - $119,067	-1,433 Reduced 10.45%	12,282 $994,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $17,745 - $19,360	-240 Reduced 1.72%	13,715 $1.03 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $91,288 - $104,126	-1,201 Reduced 7.92%	13,955 $1.08 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $4,097 - $4,668	-53 Reduced 0.35%	15,156 $1.26 Million

Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $16,951 - $24,335	-272 Reduced 1.76%	15,209 $1.31 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $10,419 - $11,901	-175 Reduced 1.12%	15,481 $955,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $2,886 - $3,250	-50 Reduced 0.32%	15,656 $968,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $57,977 - $72,652	-1,001 Reduced 5.99%	15,706 $934,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $101,602 - $115,320	-1,566 Reduced 8.57%	16,707 $1.21 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $31,814 - $34,324	-470 Reduced 2.51%	18,273 $1.28 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $43,350 - $47,366	-683 Reduced 3.52%	18,743 $1.29 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $15,780 - $18,004	-263 Reduced 1.34%	19,426 $1.26 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $5,778 - $6,584	-102 Reduced 0.52%	19,689 $1.15 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $736,381 - $925,872	11,858 Added 149.48%	19,791 $1.25 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1,808 - $2,100	-25 Reduced 0.31%	7,933 $610,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $4,384 - $5,615	-70 Reduced 0.87%	7,958 $595,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $494,685 - $544,137	8,028 New	8,028 $522,000

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.

Account

Mission Creek Capital Partners, Inc. Gilead Sciences, Inc. Transaction History